ScholarMate
客服热线:400-1616-289

Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer

Huang, Weicai; Jiang, Yuming; Xiong, Wenjun; Sun, Zepang; Chen, Chuanli; Yuan, Qingyu; Zhou, Kangneng; Han, Zhen; Feng, Hao; Chen, Hao; Liang, Xiaokun; Yu, Shitong; Hu, Yanfeng; Yu, Jiang; Chen, Yan; Zhao, Liying; Liu, Hao; Zhou, Zhiwei; Wang, Wei*; Xu, Yikai*; Li, Guoxin*
Science Citation Index Expanded
广东省人民医院; 广州中医药大学; 北京科技大学; 南方医科大学; 中山大学; 中国科学院; 1

摘要

Tumour microenvironment has been linked with immunotherapy response in gastric cancer. Here, the authors use CT-based radiomics to predict neutrophils-to-lymphocyte ratio and response to immunotherapy. @@@ The tumor immune microenvironment (TIME) is associated with tumor prognosis and immunotherapy response. Here we develop and validate a CT-based radiomics score (RS) using 2272 gastric cancer (GC) patients to investigate the relationship between the radiomics imaging biomarker and the neutrophil-to-lymphocyte ratio (NLR) in the TIME, including its correlation with prognosis and immunotherapy response in advanced GC. The RS achieves an AUC of 0.795-0.861 in predicting the NLR in the TIME. Notably, the radiomics imaging biomarker is indistinguishable from the IHC-derived NLR status in predicting DFS and OS in each cohort (HR range: 1.694-3.394, P < 0.001). We find the objective responses of a cohort of anti-PD-1 immunotherapy patients is significantly higher in the low-RS group (60.9% and 42.9%) than in the high-RS group (8.1% and 14.3%). The radiomics imaging biomarker is a noninvasive method to evaluate TIME, and may correlate with prognosis and anti PD-1 immunotherapy response in GC patients.

关键词

NEUTROPHILS RADIOMICS ANTIBODY CHEMOTHERAPY INFLAMMATION